Cannabis Use Disorders, 1st Edition

  • Ivan D. Montoya
  • Susan R.B. Weiss
  • Published By:
  • ISBN-10: 3319903659
  • ISBN-13: 9783319903651
  • DDC: 616.8635
  • 271 Pages | eBook
  • Original Copyright 2019 | Published/Released December 2020
  • This publication's content originally published in print form: 2019

  • Price:  Sign in for price



This book is an unbiased scientific compendium documenting the state-of-the-art in the etiology, diagnosis and treatment of Cannabis Use Disorders (CUD). Unlike any other current medical text, this volume focuses on the scientific aspects of CUDs and provides a resource for researchers, physicians and other health care providers who treat patients suffering from the disorder or its consequences. It begins by establishing the landscape of the disorder, including its prevalence, association with disabilities and comorbidities, and frequency of patients seeking treatment. The text delves into the complexity of the disorder in today's environment by including the discoveries on the nature and extent of the endocannabinoid system as well as potential breakthroughs in safe and effective pharmacological and nonpharmacological treatments. Experts in the field contribute discussions on the most cutting-edge diagnostic and biological topics, including genetics, medical consequences, and clinical manifestations. The text also covers the challenges and risks presented by external factors, including social repercussions, protective factors, psychiatric comorbidities, withdrawal, and treatment services. This title is a vital resource for researchers, psychiatrists, psychologists, addiction medicine specialists, toxicologists, hospital administrators, nurses, social workers, and all health care professionals working with patients who misuse cannabis.

Table of Contents

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
1: Introduction to Cannabis Use Disorders.
2: Epidemiology of Cannabis Use Disorder.
3: Genetic Aspects of Cannabis Use Disorder.
4: The Endogenous Cannabinoid System: A Cadre of Potential Therapeutic Targets.
5: Cannabidiol and Cannabis Use Disorder.
6: The Molecular Basis of Cannabinoid Activity: Application to Therapeutics Design and Discovery for Cannabis Use Disorders.
7: Translation of CUD Therapeutics from Drug Discovery to the Clinic.
8: Animal Models of Cannabis Use Disorder.
9: Human Laboratory Models of Cannabis Use Disorder.
10: Clinical Manifestations of Cannabis Use Disorder.
11: Cannabis Withdrawal.
12: Cannabis and Cannabinoid Intoxication and Toxicity.
13: Psychiatric Comorbidity of Cannabis Use Disorder.
14: The Association Between Cannabinoids and Psychosis.
15: Medical Consequences of Cannabis Use.
16: Synthetic Cannabinoid Use.
17: Cannabis Use Disorder During the Perinatal Period.
18: Cannabis Use Disorder as a Developmental Disorder.
19: Cannabinoids to Treat Cannabis Use Disorders.
20: Neurotransmitter and Neuropeptide Targets for Cannabis Use Disorder Treatment.
21: Anticonvulsants to Treat Cannabis Use Disorder.
22: Prodrugs as Treatments for Cannabis Use Disorder: N-Acetylcysteine as a Case Example.
23: Non-pharmacological Treatments for Cannabis Use Disorders.
24: Mindfulness-Based Practices for the Treatment of Cannabis Use Disorder.
25: Cannabis Use Disorder Treatment and Reimbursement.
26: International Aspects of CUD.